Skip to main content
. Author manuscript; available in PMC: 2019 Oct 29.
Published in final edited form as: Alzheimers Dement. 2017 Mar 22;13(4):e1–e85. doi: 10.1016/j.jalz.2016.11.007

Table 4.

Novel CSF blood biomarkers

Analyte CSF or plasma Association with AD pathology Notes Reference
α-1-microglobulin CSF Regional atrophy [157]
Apolipoprotein CIII CSF Regional atrophy [157]
Apolipoprotein D CSF Regional atrophy [157]
Brain-derived neurotrophic factor Plasma Neuroprotective [165]
Brain-derived neurotrophic factor Plasma NOT HV, M Val66Met polymorphism [164]
CD40 antigen CSF [162]
Chromogranin A CSF WBA Aβ dependent [159]
Chromogranin A CSF MCI to AD [166]
Cystatin CSF WBA, HA Aβ dependent [159]
Factor H CSF CD, VE [167]
Fatty acid binding protein CSF [162]
Fatty acid binding protein CSF CN to MCI [168]
Fatty acid binding protein CSF MCI to AD [166]
Ferritin CSF Regional atrophy Aβ independent [157]
Hepatocyte growth factor CSF Regional atrophy Aβ independent [157]
Hepatocyte growth factor CSF [162]
Interleukin 16 CSF Regional atrophy [157]
Interleukin 6 CSF Regional atrophy [157]
Lipoprotein A CSF [162]
Neurofilament light CSF CS, CD, WMC WBA, C, HA [160]
Neurogranin CSF CS, C, Met, HV Aβ dependent [158]
Prolactin CSF [162]
Resistin CSF [162]
S100β CSF Regional atrophy Aβ independent [157]
Trefoil factor 3 CSF WBA, HA, VE Aβ dependent [159]
Vascular endothelial growth factor CSF WBA Aβ dependent [159]
Vascular endothelial growth factor CSF HV, HA, CD Neuroprotective, effect enhanced in Aβ+ [161]
Vascular endothelial growth factor CSF [162]

Abbreviations: CSF, cerebrospinal fluid; AD, Alzheimer’s disease; HV, hippocampal volume; M, memory; WBA, whole brain atrophy; HA, hippocampal atrophy; CD, cognitive decline; VE, ventricular expansion; CN, cognitively normal; MCI, mild cognitive impairment; CS, clinical status; WMC, white-matter change; Met, metabolism; C, cognition.